These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
91 related items for PubMed ID: 9380131
1. Treatment of rheumatoid arthritis with a tumor necrosis factor receptor-Fc fusion protein. Mannik M, Wener M. N Engl J Med; 1997 Nov 20; 337(21):1560; author reply 1560-1. PubMed ID: 9380131 [No Abstract] [Full Text] [Related]
2. Treatment of rheumatoid arthritis with a recombinant human tumor necrosis factor receptor (p75)-Fc fusion protein. Moreland LW, Baumgartner SW, Schiff MH, Tindall EA, Fleischmann RM, Weaver AL, Ettlinger RE, Cohen S, Koopman WJ, Mohler K, Widmer MB, Blosch CM. N Engl J Med; 1997 Jul 17; 337(3):141-7. PubMed ID: 9219699 [Abstract] [Full Text] [Related]
3. Treatment of rheumatoid arthritis with a tumor necrosis factor receptor-Fc fusion protein. Epstein WV. N Engl J Med; 1997 Nov 20; 337(21):1559-60; author reply 1560-1. PubMed ID: 9380130 [No Abstract] [Full Text] [Related]
5. [Treatment of rheumatoid arthritis by inhibition of tumor necrosis factor with infliximab or etanercept]. Tijhuis GJ, van de Putte LB, Breedveld FC. Ned Tijdschr Geneeskd; 2001 Sep 29; 145(39):1880-5. PubMed ID: 11605312 [Abstract] [Full Text] [Related]
8. Tumor necrosis factor inactivation in the management of rheumatoid arthritis. Baumgartner SW. South Med J; 2000 Aug 29; 93(8):753-9. PubMed ID: 10963503 [Abstract] [Full Text] [Related]
9. Intravenous human recombinant tumor necrosis factor receptor p55-Fc IgG1 fusion protein Ro 45-2081 (lenercept): a double blind, placebo controlled dose-finding study in rheumatoid arthritis. Rau R, Sander O, van Riel P, van de Putte L, Hasler F, Zaug M, Kneer J, van der Auwera P, Stevens RM, Rheumatology Group 791. J Rheumatol; 2003 Apr 29; 30(4):680-90. PubMed ID: 12672184 [Abstract] [Full Text] [Related]
11. The anti-TNF revolution in ankylosing spondylitis: patients with severe disease now have access to promising new drugs. Schachna L. Med J Aust; 2004 Nov 15; 181(10):529-30. PubMed ID: 15540959 [No Abstract] [Full Text] [Related]